Liquidity & Technical

Liquidity & Technical

A 50% drawdown from the 2025 all-time high has put CSU at the 13th percentile of its 52-week range, with realized volatility in a "stressed" regime and the 50-day moving average sitting well below a still-falling 200-day. Headline daily turnover of roughly $208M is enough for most funds to hold a normal position, but the build/exit math is measured in weeks, not days — this is a long-duration compounder being traded on the tape, and execution patience is the constraint.

Portfolio implementation verdict

5-day capacity (20% ADV)

$218M

Largest issuer position cleared in 5d (% mcap)

0.39

Supported fund AUM, 5% weight (20% ADV)

$4,353M

ADV 20d / market cap (%)

0.38

Technical scorecard (−6 to +6)

-3

Price snapshot

Last price

$2,612.34

YTD return

-19.3%

1y return

-47.6%

52-week position

12.6%

Realized vol 30d (annualized, %)

47.4

Realized vol is shown in place of beta — a market beta was not derivable from the available benchmark series (the EWC overlay required for the country regression was not populated this run). The 30-day realized of 47% is, on its own, enough to flag a stressed regime.

The critical chart — 10-year price vs 50- and 200-day moving averages

Loading...

A decade of essentially monotonic compounding (533 → 5,067 from 2016 through Q3 2025, roughly 25% CAGR) reversed in three months. Price is now in a clearly defined downtrend — below the 200-day, below the previous two years of price action, and back at levels last seen in early 2023.

Relative strength

The relative strength comparison versus the broad-market benchmark (EWC) and a sector ETF could not be rendered — the benchmark series were not populated in this run (benchmarks: {} in the relative-performance file, no peer basket constructed). What can be said unambiguously from the absolute return data: a 1-year return of −47.6% is roughly 50 percentage points worse than any plausible Canadian-equity index, so the relative-strength sign is unambiguously negative even without a chart. We will treat relative strength as confirmed negative in the scorecard rather than fabricate the overlay.

Momentum — RSI(14) and MACD histogram (18 months)

Loading...
Loading...

Momentum is the only constructive piece of the tape. RSI bottomed at 20–22 in late January and early February 2026 — a level not previously visited in this dataset — and has rebuilt to a neutral 49. The MACD histogram has flipped positive on two of the last three readings (today's daily reading is +11.1 with the MACD line crossing above signal for the first time since February), echoing the bounce in price off the $2,260 area in February. This is consistent with a tactical countertrend rally inside a primary downtrend, not the start of a new uptrend — the RSI hasn't reached 70 since February 2025.

Volume, volatility, and sponsorship

Loading...

The volume signature confirms institutional distribution, not retail panic. Average daily volume tripled from ~30k shares pre-August 2025 to a peak of ~145k in late March 2026 as the price was being marked down; volume has begun fading on the recent bounce (April–May 92k, well below the March 145k peak). That is the textbook shape of a stock where holders sold into the breakdown and the rebound is being driven by absence-of-supply rather than fresh demand — bearish for a sustained turn until volume confirms higher prices.

No Results

The largest single-day volume spikes in the 10-year history are all from option-expiry / index-rebalance windows (September quadwitching, June Russell rebalance) and produced muted price reactions — i.e., they were forced-flow days, not information days. The catalyst column is intentionally blank: there is no public news event matched to these dates in the available research corpus, and labelling them speculatively would be misleading.

Loading...

10-year percentile bands frame the regime: p20 = 18%, p50 = 23%, p80 = 30%. The current 30-day realized of 47% — and the March 2026 peak of 60% — sit well above the p80 "stressed" line and represent the highest sustained volatility level since the 2022 bear market. A risk model that sized this position on 22% normal vol would be carrying double the intended factor risk today.

Institutional liquidity panel

ADV and turnover

ADV 20d (shares)

83,310

ADV 20d (value)

$208M

ADV 60d (shares)

125,337

ADV 20d / mkt cap (%)

0.38

Annual turnover (%)

91.3

The 60-day ADV (125k shares) is meaningfully higher than the 20-day (83k shares), reflecting the late-March volume spike during the breakdown. Sustainable run-rate turnover sits closer to the 20-day reading; sizing should use the lower number to be conservative.

Fund-capacity table — supported AUM by position weight

No Results

A fund holding CSU at a 5% portfolio weight can size up to roughly $4.4B AUM at a 20% ADV cap (and $2.2B at a more disciplined 10% cap). At a 10% concentrated weight, the supported book shrinks to ~$2.2B / $1.1B. Anything north of those numbers requires either patient block sourcing, splitting fills across weeks, or accepting that a single position adjustment will move the tape.

Liquidation runway — days to exit issuer-level positions

No Results

None of the three issuer-level position sizes (0.5%, 1%, 2% of market cap) can be exited inside five trading days at a normal 20% ADV participation cap — the smallest takes seven sessions, the largest takes more than a month. The largest position that can be exited in five days is approximately 0.35% of market cap (~$195M) at 20% ADV, or 0.18% (~$100M) at 10% ADV. Median 60-day daily range of 1.85% is elevated (above the 2% threshold normally used as the "impact-cost flag" for block orders), so even those modest sizes will pay meaningful slippage if worked aggressively.

Implementation read

The capacity table answers the question directly: this stock is implementable for any fund up to $4.4B that wants a 5% weight, but the build-and-exit clock runs in weeks. For multi-billion mandates, a 5% weight requires staging in over four to eight weeks at 20% ADV; a 2% weight requires two to three weeks. The volatile tape makes patient execution mandatory rather than optional — at 1.85% intraday range and 47% realized vol, an order that gets impatient and lifts offers will pay 100–200bps of unnecessary slippage.

Technical scorecard and stance

No Results

Stance: bearish on a 3–6 month horizon, with a tactical bounce window still in play. Aggregate scorecard reads −3. The primary trend is broken (death cross, price 21% below 200-day), the volume signature confirms institutional distribution rather than retail capitulation, and realized volatility is in the top decile of the 10-year distribution — none of those flip on a single rally. The constructive piece is real but narrow: RSI bottomed at a 10-year extreme and MACD has just turned, which historically supports a multi-week countertrend rally to the falling 50-day SMA / declining-tops line in the $3,300 area (also approximately the level of the 200-day). The bearish trigger that would force a re-rate is a clean weekly close below the February 2026 low of $2,260 — that breaks the recent base and opens a measured-move target into the high-$1,900s, last seen in 2022. Until either level resolves, this is a watchlist name or a slow scale-in for fundamentally constructive holders, not a momentum entry.

Liquidity is not the binding constraint on whether to own the name, but it is the binding constraint on how to act. For any fund larger than ~$2B AUM intending a 5% position, the correct posture is to build the position over four to eight weeks rather than chase the bounce — the tape will not let you do it any other way without paying for it.